201 related articles for article (PubMed ID: 37723117)
1. Effects of PCSK9 inhibitors on coronary microcirculation, inflammation and cardiac function in patients with CHD after PCI: a protocol for systematic review and meta-analysis.
Ye X; Wang S; Liu X; Wu Q; Lv Y; Lv Q; Li J; Li L; Yang Y
BMJ Open; 2023 Sep; 13(9):e074067. PubMed ID: 37723117
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials.
Luo J; Liao W; Wang X; Xu R; Li W; Li W; Liu K; Huang K; Ma Y; Wang T; Yang B; Jiao L
BMJ Open; 2022 Nov; 12(11):e062046. PubMed ID: 36424111
[TBL] [Abstract][Full Text] [Related]
4. Impact of conventional lipid-lowering therapy on circulating levels of PCSK9: protocol for a systematic review and meta-analysis of randomised controlled trials.
Luo J; Huang T; Xu R; Wang X; Yang Y; Li L; Zhang X; Zhang Y; Yang R; Wang J; Yang H; Ma Y; Yang B; Wang T; Jiao L
BMJ Open; 2022 Sep; 12(9):e061884. PubMed ID: 36691198
[TBL] [Abstract][Full Text] [Related]
5. The effect of Huoxue Huayu decoction on restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.
Hou Y; Li X; Wang X; Dong T; Yang J
Medicine (Baltimore); 2022 Jan; 101(4):e28677. PubMed ID: 35089215
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of Xinkeshu on coronary artery disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Chen M; Zhong G; Men L; Liu Q; Luan J
Medicine (Baltimore); 2021 Nov; 100(46):e27912. PubMed ID: 34797346
[TBL] [Abstract][Full Text] [Related]
7. Oral Chinese patent medicines for acute myocardial infarction after percutaneous coronary intervention: A protocol for systematic review and network meta-analysis.
Zhao W; Xiong FJ; Feng SG; Li YM; Lei XH; Jia SJ
Medicine (Baltimore); 2022 Dec; 101(48):e31927. PubMed ID: 36482597
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of percutaneous coronary intervention for acute myocardial infarction complicated with chronic renal insufficiency: A protocol of systematic review and meta-analysis.
Luo L; Xu WQ; Zhong RX; Chen F; Fu YL; Zhang P; Xiao SH
Medicine (Baltimore); 2019 Jun; 98(24):e16005. PubMed ID: 31192944
[TBL] [Abstract][Full Text] [Related]
9. Effects of traditional Chinese exercise on cardiac rehabilitation after percutaneous coronary intervention: study protocol for network meta-analysis of randomised controlled trials.
Luo C; Wen J; Sun W; Li T; Yu X; Zhang T; Zhou X; Wu W; Li R
BMJ Open; 2019 Feb; 9(2):e023096. PubMed ID: 30782873
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Danhong injection on endothelial function and inflammatory factors after the percutaneous coronary intervention for coronary heart disease: A protocol of systematic review and meta-analysis of randomized controlled trials.
Li S; Duan S; Ning Y; Zhang H; Zheng Q
Medicine (Baltimore); 2020 Jul; 99(27):e20783. PubMed ID: 32629660
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.
Chu X; Wang R; Song G; Jiang X
Medicine (Baltimore); 2021 Apr; 100(13):e25356. PubMed ID: 33787637
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of acupuncture combined with Xuefu Zhuyu Decoction on major adverse cardiovascular events after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Ma Q; Cai Z; Sui L; Wang X
Medicine (Baltimore); 2022 Nov; 101(46):e31735. PubMed ID: 36401381
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of delirium after percutaneous coronary intervention in individuals hospitalised for acute myocardial infarction: protocol for a systematic review and meta-analysis.
Huang K; Lu J; Zhu Y; Cheng T; Du D; Qian X; Pan H; Wang X; Yang H; Lou S
BMJ Open; 2020 Dec; 10(12):e044564. PubMed ID: 33380487
[TBL] [Abstract][Full Text] [Related]
14. Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Zhu K; Zheng YS; Fang Y
Medicine (Baltimore); 2020 Oct; 99(44):e22918. PubMed ID: 33126352
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of in-stent restenosis in patients with diabetes mellitus after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Li S; Luo C; Chen H
Medicine (Baltimore); 2021 Apr; 100(15):e25484. PubMed ID: 33847656
[TBL] [Abstract][Full Text] [Related]
16. Cardiac rehabilitation of Baduanjin exercise in coronary heart disease after PCI: A protocol for systematic review and meta-analysis of randomized controlled trials.
Li XX; Fan ZJ; Cui J; Lin Q; Zhuang R; Liu RP; Wu Y
Medicine (Baltimore); 2021 Apr; 100(15):e25501. PubMed ID: 33847664
[TBL] [Abstract][Full Text] [Related]
17. Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention.
Navarese EP; Kołodziejczak M; Petrescu A; Wernly B; Lichtenauer M; Lauten A; Buffon A; Wanha W; Pestrichella V; Sardella G; Contegiacomo G; Tantry U; Bliden K; Kubica J; Gurbel PA
Expert Rev Cardiovasc Ther; 2018 Jun; 16(6):419-429. PubMed ID: 29737886
[TBL] [Abstract][Full Text] [Related]
18. Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention: A protocol for a systematic review and network meta-analysis.
Zhu Z; Wang Y; Liao W; Li H; Wang D
Medicine (Baltimore); 2018 Jun; 97(24):e11062. PubMed ID: 29901609
[TBL] [Abstract][Full Text] [Related]
19. Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial.
Huang Z; Zhuang X; Zhang S; Huang Y; Yuan L; Lin A; Tang L; Xiong Z; Christopher O; Chen Y; Wu B; Ling Y; Li S; Jie Q; Xiong L; Qian X; Liao X; Liu J
BMJ Open; 2023 Jul; 13(7):e072541. PubMed ID: 37433737
[TBL] [Abstract][Full Text] [Related]
20. Effect of peer support on patient anxiety during the coronary angiography or percutaneous coronary intervention perioperative period: a protocol for a systematic review and meta-analysis of randomised controlled trials.
Qin S; Gu Y; Song T
BMJ Open; 2020 Mar; 10(3):e031952. PubMed ID: 32213516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
